Boston, MA – July 29, 2025 – The Center for the Evaluation of Value and Risk in Health (CEVR), part of the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, is pleased to announce the appointment of David Strutton, PhD, as Senior Fellow. Dr. Strutton, a distinguished leader in healthcare policy, biopharmaceuticals, and health economics, will join CEVR to work with the team on research and policy related to healthcare technology assessment (HTA), real-world evidence (RWE), and reimbursement and coverage issues.
With over 30 years of leadership experience in the life sciences and biopharma sectors, including senior roles at Merck and Pfizer, Dr. Strutton brings extensive expertise in global healthcare policies issues. His work has focused on advancing access to innovative medicines and vaccines, building cross-industry collaborations, and leveraging evidence to inform policy decisions worldwide.
“I am thrilled to join CEVR and contribute to its mission of advancing evidence-based healthcare decision-making,” said Dr. Strutton. “With global healthcare systems increasingly relying on evidence of value to guide policy, I look forward to collaborating with CEVR’s well-regarded team to enhance the understanding of value, access, and health outcomes in diverse therapeutic areas.”
In his role at CEVR, Dr. Strutton will continue his work at the forefront of global healthcare innovation, helping to bridge the gap between academic research, industry practice, and policy development to ensure that innovative healthcare solutions reach the patients who need them most
“David’s wide-ranging experience in health economics, outcomes research, and global access strategy will be invaluable to the work at our Center,” said Peter Neumann, ScD, CEVR’s Director. “His leadership and vision align perfectly with our mission to advance the scientific foundations of healthcare decision-making, particularly in the realm of value and access. We are excited to welcome him aboard.”
During his time as Vice President at Merck, Dr. Strutton played a pivotal role in establishing the company's Center for Observational and Real-World Evidence (CORE) and spearheading integrated evidence strategies to support global access to Merck’s innovations. While at Pfizer, he worked to advance global access to vaccines, through work with national immunization technical advisory groups, including the CDC’s Advisory Committee on Immunization Practice (ACIP).
Dr. Strutton holds a PhD in Health Economics from The Johns Hopkins University Bloomberg School of Public Health, where he also served as an adjunct faculty member for nearly two decades. He also earned an MPH from The George Washington University and a BA in Economics from the University of Rochester. Dr. Strutton has served on multiple advisory boards and research committees, including those for the Institute for Clinical and Economic Review (ICER) and the National Pharmaceutical Council.
About CEVR
CEVR is a national leader on research on the value of health and medical interventions, with the goal of supporting better societal decision-making on health care spending. CEVR is a part of Tufts Medical Center’s Institute for Clinical Research and Health Policy Studies (ICRHPS). We undertake scientific research projects, advance methods development for the field, train the next generation of practitioners and users, and work with policymakers worldwide to develop reasoned policy solutions.
Contact Information
Matt Seidner, Senior Program Manager
matthew.seidner@tuftsmedicalcenter.org
